The overuse of antibiotics is increasingly leading to the emergence of infectious superbugs—dangerous bacteria that have developed antimicrobial resistance (AMR) and are therefore much harder, if not impossible, to eliminate ...
May 27, 2026
0
3
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor growth and stayed hidden ...
Mar 12, 2026
0
23
QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon and pancreatic cancers. The findings are published in the journal Talanta.
Mar 4, 2026
0
10
As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these therapies forecast to double ...
Feb 9, 2026
0
11
A vaccine created by University of Georgia researchers to battle multiple life-threatening fungal infections is also effective against Candida auris in mice, according to a new study published in Vaccines by researchers in ...
Jan 20, 2026
0
9
Breast cancer is on the rise, but new tools for early detection could save lives. In Journal of Vacuum Science & Technology B, researchers from the University of Florida and National Yang Ming Chiao Tung University in Taiwan ...
Feb 13, 2024
0
67
Three years ago, the world stood on the precipice of a pandemic.
Mar 13, 2023
0
25
A team of medical specialists working at Memorial Sloan Kettering Cancer Center in New York has found that donated white blood cells can be used effectively as part of CAR T cell therapy to treat myeloma patients.
Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.
Nov 5, 2022
0
129
According to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show that the drug, lecanemab, reduced clinical decline of people with Alzheimer's ...
Oct 4, 2022
0
51
